The first group was dubbed "gram-positive," while the latter was designated "gram-negative." Related: Dangerous 'superbugs' are a growing threat, and antibiotics can't stop their rise. What can?

noninterventional registry developed to collect real-world data on the use of daptomycin in the treatment of patients with Gram-positive infections. This subgroup analysis evaluated the safety and ...